2nd Edition of
International Vaccines Congress
Event Book
Event program
Scientific Program
About
We are delighted to extend our heartfelt gratitude to all participants, speakers, and attendees for making the “2nd Edition of International Vaccines Congress” (IVC 2022) a resounding success. The virtual event, held on October 19-20, 2022, truly lived up to its meaningful theme, “Synergy to Rehabilitate Innovations in Vaccine Research and Development.” IVC 2022 provided a vibrant international multidisciplinary platform that brought together professionals, researchers, and world-class scientists from the field of vaccine research. Your active participation and insightful contributions greatly enriched the conference. The event featured keynote addresses, oral and poster presentations, and dynamic discussions focused on a wide range of scientific sessions, from basic cell science to advanced innovations in vaccinations and their applications for healthcare improvement.
Scientific Committee Members
Vincenzo Alfano
University of Napoli Parthenope, Italy
Sudhakar Bangera
AILEEN Clinical Research Services, India
Rosane Cuber Guimaraes
Bio-Manguinhos/ Fiocruz, BrazilSpeakers
Deborah Hilton
Deborah Hilton Statistics Online, Australia
Sissy Therese Sonnleitner
Innsbruck Medical University, Austria
Christine Bricault
Sanofi Vaccines, United States
Yusuf Ziya Sener
Beypazarı State Hospital, Turkey
Angelo Tunin Chica Pergo
Faculty Of Medicine Of Itajuba, Brazil
Seyedeh Sajedeh Mousavi
Islamic Azad University, Iran (Islamic Republic of)
Solange Whegang Youdom
University of Dschang, Cameroon
Jamil M A S Obaid
Ibb University, YemenGallery
Reviews
Important Alert:
X
Title : The need for separate regulations for prophylactic vaccines
Sudhakar Bangera, AILEEN Clinical Research Services, India
Title : Analytical transfer of COVID-19 recombinant vaccine between fiocruz and astrazeneca
Rosane Cuber Guimaraes, Bio-Manguinhos/ Fiocruz, Brazil
Title : Your vaccine attitude determines your altitude what are the determinants of attitude toward vaccination?
Vincenzo Alfano, University of Napoli Parthenope, Italy
Title : Therapeutic repositioning of the monoclonal antibodies itolizumab and nimotuzumab in COVID-19.
Mayra Ramos Suzarte, Center of Molecular Immunology, Cuba
Title : Robust antibody-mediated protection against SARS-CoV-2 induced by NVX-CoV2373 subunit vaccine adjuvanted with matrix-M
Alex Zhu, University of Duisburg-Essen, United States
Title : Development and validation of a specific tool to assess vaccination hesitation during the COVID-19 pandemic
Angelo Tunin Chica Pergo, Faculty Of Medicine Of Itajuba, Brazil